TUCSON   520.748.4400

Spirogen Ltd.

Spirogen was founded to commercialize a platform technology capable of discovering lead compounds that target any gene sequence. The company’s work has led to novel toxic anticancer therapeutics for use in antibody drug conjugates (ADCs).